KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Total Non-Current Liabilities (2016 - 2021)

Historic Total Non-Current Liabilities for Abbott Laboratories (ABT) over the last 13 years, with Q4 2021 value amounting to -$14.0 billion.

  • Abbott Laboratories' Total Non-Current Liabilities fell 3556.39% to -$14.0 billion in Q4 2021 from the same period last year, while for Dec 2021 it was -$14.0 billion, marking a year-over-year decrease of 3556.39%. This contributed to the annual value of -$14.0 billion for FY2021, which is 3556.39% down from last year.
  • According to the latest figures from Q4 2021, Abbott Laboratories' Total Non-Current Liabilities is -$14.0 billion, which was down 3556.39% from -$10.4 billion recorded in Q4 2020.
  • Abbott Laboratories' 5-year Total Non-Current Liabilities high stood at $47.4 billion for Q4 2017, and its period low was -$14.0 billion during Q4 2021.
  • For the 5-year period, Abbott Laboratories' Total Non-Current Liabilities averaged around $10.0 billion, with its median value being -$10.4 billion (2020).
  • In the last 5 years, Abbott Laboratories' Total Non-Current Liabilities skyrocketed by 11025.63% in 2017 and then crashed by 13050.56% in 2019.
  • Quarter analysis of 5 years shows Abbott Laboratories' Total Non-Current Liabilities stood at $47.4 billion in 2017, then decreased by 18.53% to $38.6 billion in 2018, then tumbled by 130.51% to -$11.8 billion in 2019, then increased by 12.12% to -$10.4 billion in 2020, then crashed by 35.56% to -$14.0 billion in 2021.
  • Its Total Non-Current Liabilities stands at -$14.0 billion for Q4 2021, versus -$10.4 billion for Q4 2020 and -$11.8 billion for Q4 2019.